FindTrial
Sign In

Assessing the incidence and severity of chemotherapy induced nausea and vomiting in children with cancer: A study at a tertiary cancer centre

Assessment of incidence and severity of chemotherapy induced nausea and vomiting in children with cancer on antiemetics: A prospective survey at a tertiary cancer centre

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/08/044822
Enrollment
105
Registered
2022-08-23
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C81-C96- Malignant neoplasms of lymphoid, hematopoietic and related tissue

Interventions

None listed

Sponsors

Kasturba Medical College Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children with cancer under the age of 18 receiving chemotherapy with moderate to severe emetogenicity. Patients or caregivers who consent to take part in the survey and the use of data for research purposes

Exclusion criteria

Exclusion criteria: Patients or caregivers who do not consent to take part in the survey or the use of data for research purposes.

Design outcomes

Primary

MeasureTime frame
Incidence and severity of chemotherapy induced nausea and vomitingTimepoint: Single time point at entry to study—

Secondary

MeasureTime frame
Severity of chemotherapy induced nausea and vomitingTimepoint: Single time point at entry to study—

Countries

India

Contacts

Public ContactDr Vasudeva Bhat K

Kasturba Medical College Manipal

vasudev.bhat@manipal.edu

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026